About the Partner
npj Regenerative Medicine is a part of the Nature Partner Journals series and is published in a partnership between Nature Research, Monash University (Melbourne, Australia) and the Australian Regenerative Medicine Institute (ARMI; Melbourne, Australia).
Monash University was established in Melbourne, Australia in 1958. Since its establishment, Monash has become known for producing research that has an influence well beyond the academic community.
Many of Monash’s researchers have made discoveries leading to significant and lasting impacts, in Australia and around the world. Monash’s focus is on research that is not limited by disciplinary or institutional barriers, but finds ways to overcome these hurdles.
Monash’s research goals can be summarised in three words: excellence, relevance and impact. Monash believes that these goals are mutually supporting, and that with these guiding aims their research can continue to solve the challenges society faces.
To achieve Monash’s overarching research goals, they are increasing their capacity to connect with industry, government and the world’s very best research organisations. Monash are also breaking down the traditional barriers between fields of study, creating cross-disciplinary teams involving multiple faculties. Fundamental to Monash’s approach is an unrelenting commitment to excellence and support for our emerging and established research leaders.
ARMI is a $153 million medical research centre that officially opened in April 2009. It is based at the Clayton campus of Monash University. Established through a joint venture between Monash University and the Victorian Government, ARMI builds on the University's existing strengths in biomedical research and supports the critical infrastructure required to deliver the next generation of discoveries in regenerative medicine.
At full capacity ARMI will be one of the world's largest regenerative medicine and stem cell research centres. Its scientists focus on unravelling the basic mechanisms of the regenerative process, aiming to eventually enable doctors to prevent, halt and reverse damage to vital organs due to disease, injury or genetic conditions. This work will form the basis of treatments for conditions such as neurodegenerative disorders, diabetes, arthritis, musculo-skeletal and cardiovascular diseases.